Case report reveals incomplete Denys-Drash syndrome caused by a WT1 variant in a male infant, highlighting the necessity of genetic testing for accurate nephrotic syndrome diagnosis.
Infantile nephrotic syndrome (INS) has a slower progression to end-stage kidney disease (ESKD) than congenital nephrotic syndrome (CNS). The genetic variants are non-Finnish-type related; Denys-Drash syndrome (DDS) is the most frequent syndromic disease, characterized by a first-year onset of steroid-resistant nephrotic syndrome, disorder of sex development, predisposition to Wilms tumor, and diffuse mesangial sclerosis (DMS) in kidney biopsy. We report a previously healthy male infant with steroid-resistant nephrotic syndrome (SRNS), cryptorchidism, focal and segmental glomerular sclerosis (FSGS) with pseudo-cystic dilation of proximal tubules, initially interpreted as a genetic, non-syndromic nephrotic syndrome. A WT1 missense likely pathogenic variant was identified, then classified as incomplete Denys-Drash syndrome. We describe the phenotype of an unusual variant. The phenotypic heterogeneity of WT1-associated nephropathy can lead to a misdiagnosis, highlighting the importance of genetic testing in INS to achieve a correct diagnosis and provide the best treatment and surveillance according to the identified genetic variant.
No takes yet. Share an insight, caveat, or question.
Zamora et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: